John Landis
Director/Board Member bei EYEPOINT PHARMACEUTICALS, INC.
Vermögen: 235 638 $ am 31.03.2024
Profil
John Barry Landis is an Independent Director at EyePoint Pharmaceuticals, Inc. and a Member-Chemistry Leadership Council at Purdue University.
He is also the President of Exelead, Inc. In the past, he served as Chairman at Inotiv, Inc. and held director positions at Immunomedics, Inc., NanoMed Pharmaceuticals, Inc., Metabolic Solutions Development Co. LLC, Symphogen A, and Morrill Motors, Inc. He was also a Vice President at Pharmacia & Upjohn, Inc. and held senior vice president positions at Schering-Plough Corp., The Upjohn Co., and Pharmacia Corp.
He was an Advisory Board member at Southwest Michigan.
First (Venture Capital).
Dr. Landis received his undergraduate degree from Kent State University (Ohio) and his graduate and doctorate degrees from Purdue University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.01.2024 | 11 400 ( 0,02% ) | 235 638 $ | 31.03.2024 |
Aktive Positionen von John Landis
| Unternehmen | Position | Beginn |
|---|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Director/Board Member | 25.10.2018 |
| Purdue University | Corporate Officer/Principal | - |
Exelead, Inc.
 Exelead, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Exelead, Inc. is a biopharmaceutical contract development and manufacturing company. The private company is based in Indianapolis, IN. John Rigg has been the CEO of the company since 2014. Exelead was acquired by Merck KGaA from Leadiant Biosciences SA on February 23, 2022 for $780 million. | President | - |
Ehemalige bekannte Positionen von John Landis
| Unternehmen | Position | Ende |
|---|---|---|
| INOTIV, INC. | Chairman | 18.07.2016 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 01.10.2008 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 01.01.2003 |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Director/Board Member | - |
Ausbildung von John Landis
| Kent State University (Ohio) | Undergraduate Degree |
| Purdue University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INOTIV, INC. | Commercial Services |
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
| Pharmacia & Upjohn, Inc. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
| The Upjohn Co. | Health Technology |
NanoMed Pharmaceuticals, Inc.
 NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services NanoMed Pharmaceuticals, Inc. developed therapeutic and diagnostic products. The company was founded by Michael Jay, Stephen Benoit and Russell J. Mumper in 2000 and was headquartered in Kalamazoo, MI. | Commercial Services |
Metabolic Solutions Development Co. LLC
 Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
Morrill Motors, Inc.
 Morrill Motors, Inc. Electrical ProductsProducer Manufacturing Part of Regal Rexnord Corp., Morrill Motors, Inc. is a private company that manufactures electric motors. The company is based in Erwin, TN. Morrill Motors was acquired by Regal Rexnord Corp. on October 12, 2007. | Producer Manufacturing |
Southwest Michigan First (Venture Capital)
 Southwest Michigan First (Venture Capital) Investment ManagersFinance Founded in 2000, Southwest Michigan First is a privately-funded, non-profit corporation and venture capital investor located in Kalamazoo, Michigan. They are a subsidiary of the Southwest Michigan First Corp. and are affiliated with the Southwest Michigan First Life Science Fund which was formed in 2004. | Finance |
Exelead, Inc.
Exelead, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Exelead, Inc. is a biopharmaceutical contract development and manufacturing company. The private company is based in Indianapolis, IN. John Rigg has been the CEO of the company since 2014. Exelead was acquired by Merck KGaA from Leadiant Biosciences SA on February 23, 2022 for $780 million. | Health Technology |
